The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement.

The Efficacy of Ultrasound Guided Suprainguinal Fascia Iliaca Compartment Block for Acute Paint Control After Elective Total Hip Replacement Using Postero-lateral Approach

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04690647

Enrollment

150

Registered

2020-12-31

Start date

2018-09-28

Completion date

2019-12-20

Last updated

2020-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Analgesia, Arthropathy of Hip

Brief summary

Total hip replacement surgery is one of the most common orthopedic interventions. Proper anaesthesia and adequate analgesia is one of the key interests of attending anaesthetist. Recent studies show that ultrasound guided suprainguinal fascia iliaca compartment block may play a significant role in proper management of pain after these procedures. The aim of this study was to assess the clinical usefulness and compare different methods of anaesthesia for total hip replacement surgery via posterolateral approach.

Interventions

OTHEROpioid and non opioid postoperative analgesia.

Postoperative analgesia will be based on opioid and non opioid analgesics according to standardised protocol.

OTHERFascia iliaca compartment block

Ultrasound guided suprainguinal fascia iliaca compartment block will be performed using 0.375% ropivacaine and 5ug/ml adrenaline according to standardised protocol.

DRUGDexamethasone

Dexamethasone will be administered preoperatively in a dose of 0,1 mg/kg.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* age 18-75 years old * informed consent to participate in the study * ASA score I-III * BMI -19-30kg/m2 * qualified for total hip replacement * no contraindication to used anesthesia and drugs

Exclusion criteria

* contraindications to spinal anesthesia and regional blocks * previously coexisting chronic pain * previously opioids intake * BMI\>30kg/m2 * allergy to drugs using during study * mental status preventing the usage of patient controlled analgesia pump

Design outcomes

Primary

Measure	Time frame	Description
Opioid consumption [mg]	48 hours	Postoperative opioid consumption was noted.
Opioid related adverse effects	48 hours	Postoperative incidence of nausea, vomiting, constipation and apnea were noted.
Hospital stay [days]	31 days	Total length of hospital stay was noted.

Secondary

Measure	Time frame	Description
Likert scale	31 days	Likert scale value was noted at the discharge. Value of 1 corresponded with strong dissatisfaction, value of 2 with dissatisfaction, value of 3 with neither satisfaction nor dissatisfaction, value of 4 with satisfaction, value of 5 with strong satisfaction.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026